New Key Statistics Module, Z-Score and F-Score
NAS:AVDL Key Ratios
Market Cap $ M | 1,614.08 |
Enterprise Value $ M | 1,497.15 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 18.18 |
Price/Sales | 56.95 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 27.00 |
EPS (TTM) $ | -2.01 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -9.92 |
EV-to-EBITDA | -10.04 |
PEG | -- |
Shares Outstanding M | 90.58 |
Net Margin (%) | -573.17 |
Operating Margin % | -492.97 |
Pre-tax Margin (%) | -574.96 |
Quick Ratio | 3.36 |
Current Ratio | 3.64 |
ROA % (ttm) | -95.14 |
ROE % (ttm) | -284.41 |
ROIC % (ttm) | -211.06 |
Dividend Yield % | -- |
Altman Z-Score | 3.99 |
AVDL Number of Guru Trades
AVDL Volume of Guru Trades
Gurus Latest Trades with NAS:AVDL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AVDL is held by these investors
Total 1
Avadel Pharmaceuticals PLC Insider Transactions
No Available Data
News about NAS:AVDL
Total 0- 1